From Nasdaq Inc.: 2025-06-12 23:00:00

UCB plans to invest in a new biologics manufacturing facility in the U.S., projected to have a $5 billion economic impact and create 300 permanent jobs. The company is conducting a feasibility study to determine the ideal location, focusing on regions with strong talent pipelines and innovation ecosystems.



Read more at Nasdaq Inc.: UCB To Invest In U.S. Biologics Facility With $5 Bln Economic Impact